Titel	Veröffentlichungsdatum	Sprache	Zitate
Effects of conventional therapeutic interventions on the number and function of regulatory T cells	2013/10/01	English	124
Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma	2013/03/01	English	121
Trial Watch	2014/03/01	English	118
Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer	2013/01/01	English	117
Trial watch	2012/10/01	English	117
Immunotherapy of hepatocellular carcinoma	2012/01/01	English	116
Vemurafenib enhances MHC induction inBRAFV600Ehomozygous melanoma cells	2013/01/01	English	111
Trial Watch	2013/08/01	English	109
Role of non-classical MHC class I molecules in cancer immunosuppression	2013/11/01	English	108
Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer	2012/03/01	English	103
The split nature of tumor-infiltrating leukocytes	2012/08/01	English	102
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy	2012/09/01	English	101
Trial watch	2013/02/01	English	100
Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis	2012/05/01	English	100
Trial watch	2012/03/01	English	99
The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors	2013/01/01	English	98
B cell-regulated immune responses in tumor models and cancer patients	2013/07/01	English	97
Blockade of PD-1 immunosuppression boosts CAR T-cell therapy	2013/10/01	English	97
NK cells and T cells cooperate during the clinical course of colorectal cancer	2014/08/03	English	95
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set	2014/04/01	English	94
A role for CCL2 in both tumor progression and immunosurveillance	2013/07/01	English	93
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo	2012/07/01	English	91
New prospects on the NKG2D/NKG2DL system for oncology	2013/10/01	English	90
Trial watch	2013/10/01	English	89
Trial Watch	2013/12/01	English	89
Trial Watch	2014/02/01	English	88
Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction	2012/12/01	English	84
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients	2012/07/01	English	84
Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology	2013/11/01	English	84
Trial watch	2013/06/01	English	84